Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: results from the Rotterdam Study

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Non-statin Treatment of Dyslipidemia Scores ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by